Heisenberg-Professur für Molekulare Mechanismen der Organfibrose

Address:
Krankenhausstraße 12
91054 Erlangen


Publications (Download BibTeX)

Go to first page Go to previous page 1 of 9 Go to next page Go to last page

Sobanski, V., Giovannelli, J., Allanore, Y., Riemekasten, G., Airo, P., Vettori, S.,... Poindron, V. (2019). Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis. Arthritis and Rheumatology. https://dx.doi.org/10.1002/art.40906
Renoux, F., Stellato, M., Vogetseder, A., Huang, R., Subramaniam, A., Blyszczuk, P.,... Distler, O. (2019). FOSL-2 IS A REPRESSOR OF FOXP3 EXPRESSION DURING TREG DEVELOPMENT AND CONTROLS AUTOIMMUNITY. In ANNALS OF THE RHEUMATIC DISEASES (pp. 1065-1065). Madrid, ES: LONDON: BMJ PUBLISHING GROUP.
Pachera, E., Assassi, S., Salazar, G., Frank-Bertoncelj, M., Distler, J., Kania, G., & Distler, O. (2019). PROFIBROTIC LNCRNA H19X: UNRAVELLING THE EFFECTS ON CHROMATIN REMODELING IN SYSTEMIC SCLEROSIS FIBROBLASTS. In ANNALS OF THE RHEUMATIC DISEASES (pp. 167-168). Madrid, ES: LONDON: BMJ PUBLISHING GROUP.
De Stefano, L., Castaneda, S., De Langhe, E., Distler, J., Knitza, J., Cavazzana, I.,... Cavagna, L. (2019). RELATIONSHIP BETWEEN ANTI-MDA5 ANTIBODIES AND CANCER: RETROSPECTIVE ANALYSIS OF AN INTERNATIONAL AND MULTIDISCIPLINARY COHORT. In ANNALS OF THE RHEUMATIC DISEASES (pp. 1212-1212). Madrid, ES: LONDON: BMJ PUBLISHING GROUP.
Distler, J. (2019). POTENTIAL CELLULAR AND MOLECULAR TARGETS. In ANNALS OF THE RHEUMATIC DISEASES (pp. 32-33). Madrid, ES: LONDON: BMJ PUBLISHING GROUP.
Wohlfahrt, T., Rauber, S., Luber, M., Soare, A., Weber, S., Matei, A.-E.,... Ramming, A. (2019). PU.1 INHIBITOR DB1976 CONTROLS FIBROBLAST POLARIZATION IN SYSTEMIC SCLEROSISAND LEADS TO REGRESSION OF FIBROSIS IN DIFFERENT MODELS OF ORGAN FIBROSIS. In ANNALS OF THE RHEUMATIC DISEASES (pp. 453-453). Madrid, ES: LONDON: BMJ PUBLISHING GROUP.
Henderson, J., Distler, J., & O'Reilly, S. (2019). The Role of Epigenetic Modifications in Systemic Sclerosis: A Druggable Target. Trends in Molecular Medicine, 25(5), 395-411. https://dx.doi.org/10.1016/j.molmed.2019.02.001
Wu, W., Jordan, S., Graf, N., Pena, J.D.O., Curram, J., Allanore, Y.,... Puttini, P.S. (2019). Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. Annals of the Rheumatic Diseases, 78(5), 648-656. https://dx.doi.org/10.1136/annrheumdis-2018-213455
Heim, C., Mauer, J., Kuckhahn, A., Distler, J., Spriewald, B., Ramsperger-Gleixner, M.,... Ensminger, S.M. (2019). Receptor Tyrosine Kinase Inhibitor Nintedanib as Treatment Option in Bronchiolitis Obliterans after Airway Transplantation. In JOURNAL OF HEART AND LUNG TRANSPLANTATION (pp. S139-S139). Orlando, FL, US: NEW YORK: ELSEVIER SCIENCE INC.
Wollin, L., Distler, J., Redente, E., Riches, D., Stowasser, S., & Schlenker-Herceg, R. (2019). FROM BENCH TO BEDSIDE: NINTEDANIB FOR PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES. In RESPIROLOGY (pp. 171-171). HOBOKEN: WILEY.
Harrach, S., Barz, V., Pap, T., Pavenstaedt, H., Schlatter, E., Edemir, B.,... Bertrand, J. (2019). Notch Signaling Activity Determines Uptake and Biological Effect of Imatinib in Systemic Sclerosis Dermal Fibroblasts. Journal of Investigative Dermatology, 139(2), 439-447. https://dx.doi.org/10.1016/j.jid.2018.08.021
Knitza, J., Cavagna, L., Schett, G., & Distler, J. (2019). Response to: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: Contribution of antisynthetase antibodies to improve current classification criteria' by Greco et al. Annals of the Rheumatic Diseases. https://dx.doi.org/10.1136/annrheumdis-2019-215484
Wollin, L., Distler, J., Denton, C.P., & Gahlemann, M. (2019). Rationale for the evaluation of nintedanib as a treatment for systemic sclerosis–associated interstitial lung disease. Journal of Scleroderma and Related Disorders. https://dx.doi.org/10.1177/2397198319841842
Liang, R.f., Kagwiria, R., Zehender, A., Dees, C., Bergmann, C., Ramming, A.,... Distler, J. (2019). Acyltransferase skinny hedgehog regulates TGFβ-dependent fibroblast activation in SSc. Annals of the Rheumatic Diseases. https://dx.doi.org/10.1136/annrheumdis-2019-215066
Fischer, A., & Distler, J. (2019). Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases. Clinical Rheumatology. https://dx.doi.org/10.1007/s10067-019-04720-0
Kreuter, M., Bonella, F., Blank, N., Siegert, E., Henes, J., Worm, M.,... Hunzelmann, N. (2019). Predictors for the Development of Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) - Data from the German SSc-Network. In AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. Dallas, TX, US: NEW YORK: AMER THORACIC SOC.
Wohlfahrt, T., Rauber, S., Uebe, S., Luber, M., Soare, A., Ekici, A.B.,... Ramming, A. (2019). PU.1 controls fibroblast polarization and tissue fibrosis. Nature. https://dx.doi.org/10.1038/s41586-019-0896-x
Fasano, S., Riccardi, A., Messiniti, V., Caramaschi, P., Rosato, E., Maurer, B.,... Valentini, G. (2019). Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual. Annals of the Rheumatic Diseases. https://dx.doi.org/10.1136/annrheumdis-2019-215787
Elhai, M., Boubaya, M., Distler, O., Smith, V., Matucci-Cerinic, M., Alegre Sancho, J.J.,... Allanore, Y. (2019). Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: A prospective cohort study. Annals of the Rheumatic Diseases. https://dx.doi.org/10.1136/annrheumdis-2018-214816
Storkanova, H., Oreska, S., Spiritovic, M., Hermankova, B., Pavelka, K., Vencovsky, J.,... Tomcik, M. (2018). PLASMA LEVELS OF HSP90 ARE INCREASED IN INTERSTITIAL LUNG DISEASE AND SKIN FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS. (pp. 1103-1104).

Last updated on 2019-24-04 at 10:31